![]() |
市場調查報告書
商品編碼
1699302
支氣管鏡市場機會、成長動力、產業趨勢分析及 2025-2034 年預測Bronchoscopy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 |
2024 年全球支氣管鏡市場價值為 33 億美元,預計 2025 年至 2034 年的複合年成長率為 7.2%。包括結核病、氣喘、肺癌和慢性阻塞性肺病 (COPD) 在內的呼吸系統疾病的盛行率不斷上升,推動了對支氣管鏡檢查的需求。機器人輔助支氣管鏡檢查和人工智慧成像等醫療技術的進步正在提高診斷的準確性和程序效率。人們對微創技術的日益青睞進一步推動了市場擴張。
本產業依產品類型分為硬性支氣管鏡、軟性支氣管鏡和其他相關產品。 2024 年,軟性支氣管鏡佔據最大的市場佔有率,為 57.1%,預計在整個預測期內的複合年成長率為 7.4%。高清視訊、人工智慧和窄帶成像 (NBI) 的結合顯著改善了肺部和氣道的可視化,實現了即時診斷和先進的影像處理。這些改進提高了手術效率並改善了患者的治療效果。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 33億美元 |
預測值 | 68億美元 |
複合年成長率 | 7.2% |
根據用途,市場分為一次性使用/一次使用支氣管鏡和可重複使用支氣管鏡。 2024 年,一次性/可拋棄型產品將佔據主導地位,佔有 56.3% 的佔有率。該行業正在經歷從傳統開放式手術技術向微創方法的顯著轉變,從而增加了對一次性支氣管鏡的需求。對醫院內感染 (HAI) 的擔憂進一步加速了一次性器械的採用,因為它們可以降低交叉污染風險並確保更高水準的病患安全。醫療保健環境中對感染預防協議的日益重視預計將維持對一次性支氣管鏡的需求。
2023 年美國支氣管鏡市場價值為 9.211 億美元,在全球產業中保持強勢地位。預計肺癌發病率的上升將推動手術需求,醫療保健提供者將越來越依賴支氣管鏡進行早期診斷和治療計劃。關鍵產業參與者的存在和支氣管鏡技術的不斷進步正在鞏固該國在全球市場的領導地位。隨著對精確、微創手術的需求不斷成長,支氣管鏡檢查市場在未來幾年將保持穩定成長。
The Global Bronchoscopy Market was valued at USD 3.3 billion in 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2034. The increasing prevalence of respiratory diseases, including tuberculosis, asthma, lung cancer, and chronic obstructive pulmonary disease (COPD), is driving demand for bronchoscopy procedures. Advancements in medical technology, such as robot-assisted bronchoscopies and AI-powered imaging, are improving diagnostic accuracy and procedural efficiency. The rising preference for minimally invasive techniques is further boosting market expansion.
The industry is categorized by product type into rigid bronchoscopes, flexible bronchoscopes, and other related products. Flexible bronchoscopes held the largest market share of 57.1% in 2024 and are anticipated to grow at a CAGR of 7.4% throughout the forecast period. The incorporation of high-definition video, artificial intelligence, and narrow-band imaging (NBI) has significantly improved the visualization of the lungs and airways, enabling real-time diagnostics and advanced image processing. These enhancements are increasing the efficiency of procedures and improving patient outcomes.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $3.3 Billion |
Forecast Value | $6.8 Billion |
CAGR | 7.2% |
Based on usage, the market is segmented into single-use/disposable and reusable bronchoscopes. In 2024, the single-use/disposable segment dominated with a 56.3% share. The industry is witnessing a notable shift from traditional open surgical techniques to minimally invasive approaches, increasing the demand for disposable bronchoscopes. Concerns over hospital-acquired infections (HAIs) are further accelerating the adoption of single-use instruments, as they reduce cross-contamination risks and ensure a higher level of patient safety. The growing emphasis on infection prevention protocols in healthcare settings is expected to sustain the demand for disposable bronchoscopes.
US bronchoscopy market was valued at USD 921.1 million in 2023, maintaining a strong position within the global industry. The rising incidence of lung cancer is expected to drive procedural demand, with healthcare providers increasing their reliance on bronchoscopy for early diagnosis and treatment planning. The presence of key industry players and continuous advancements in bronchoscopy technology are reinforcing the country's leadership in the global market. As demand for precise, minimally invasive procedures continues to rise, the bronchoscopy market is poised for steady growth in the years ahead.